Information in the news releases is current on the date of the announcement, but is subject to change without prior notice.
2021 Release
-
December 24, 2021
-
December 24, 2021
INVESTIGATIONAL ALZHEIMER’S DISEASE THERAPY LECANEMAB GRANTED FDA FAST TRACK DESIGNATION
-
December 22, 2021
-
December 20, 2021
-
December 20, 2021
-
December 17, 2021
-
December 16, 2021
-
December 6, 2021
-
November 30, 2021
-
November 30, 2021
-
November 29, 2021
-
November 29, 2021
-
November 19, 2021
EISAI SELECTED FOR MEMBERSHIP IN DOW JONES SUSTAINABILITY ASIA PACIFIC INDEX 2021 FOR EIGHTH TIME
-
November 18, 2021
EISAI RECEIVES THE “MOST LIKED!” IR AWARD AT THE 2021 IR AWARD
-
November 17, 2021
Update on Regulatory Review of Aducanumab in the European Union
-
November 12, 2021
-
November 12, 2021
-
November 12, 2021
-
November 11, 2021
-
November 9, 2021
-
November 4, 2021
-
November 4, 2021
-
November 1, 2021
-
October 18, 2021
-
September 28, 2021
-
September 27, 2021
-
September 14, 2021
-
September 14, 2021
EISAI TO PRESENT ABSTRACTS ON ONCOLOGY PRODUCTS AND PIPELINE AT ESMO VIRTUAL CONGRESS 2021
-
September 13, 2021
-
August 31, 2021
-
August 16, 2021
-
August 12, 2021
-
August 5, 2021
-
August 4, 2021
-
August 2, 2021
-
July 30, 2021
-
July 30, 2021
-
July 29, 2021
-
July 27, 2021
-
July 22, 2021
-
July 21, 2021
-
July 19, 2021
EISAI LAUNCHES BILE ACID TRANSPORTER INHIBITOR GOOFICE® IN THAILAND
-
July 19, 2021
-
July 8, 2021
-
June 30, 2021
-
June 29, 2021
Position and Policy Regarding Reduction in the Trading Unit of the Company's Shares
-
June 24, 2021
-
June 23, 2021
-
June 23, 2021
-
June 18, 2021
-
June 18, 2021
-
June 15, 2021
EISAI TO DIVEST RIGHTS FOR ZONEGRAN® IN EUROPE AND OTHER REGIONS TO ADVANZ PHARMA
-
June 9, 2021
-
June 9, 2021
EISAI TO PRESENT LATEST DATA OF LEMBOREXANT AT 35th ANNUAL SLEEP MEETING (SLEEP2021)
-
June 8, 2021
Biogen and Eisai launch initiatives to help patients with Alzheimer’s disease access ADUHELM™
-
June 8, 2021
-
June 7, 2021
-
May 31, 2021
-
May 20, 2021
EISAI TO PRESENT DATA ON ONCOLOGY PIPELINE AND PRODUCTS AT ASCO ANNUAL MEETING
-
May 19, 2021
-
May 14, 2021
-
May 11, 2021
-
May 6, 2021
-
April 28, 2021
-
April 23, 2021
-
April 23, 2021
-
April 23, 2021
-
April 20, 2021
-
April 14, 2021
-
April 12, 2021
-
March 31, 2021
-
March 31, 2021
-
March 30, 2021
-
March 26, 2021
-
March 23, 2021
LENVIMA®(LENVATINIB) APPROVED FOR ADDITIONAL INDICATION OF UNRESECTABLE THYMIC CARCINOMA IN JAPAN
-
March 23, 2021
-
March 22, 2021
-
March 22, 2021
-
March 19, 2021
-
March 17, 2021
-
March 16, 2021
-
March 12, 2021
-
March 5, 2021
-
March 4, 2021
EISAI CERTIFIED IN 2021 AS OUTSTANDING HEALTH AND PRODUCTIVITY MANAGEMENT ORGANIZATION (WHITE 500)
-
March 4, 2021
EISAI TO SUPPORT CONSTRUCTION OF SCREENING FRAMEWORK FOR THE NOVEL CORONAVIRUS INFECTION IN KENYA
-
March 2, 2021
-
February 22, 2021
-
February 22, 2021
-
February 15, 2021
-
February 3, 2021
-
February 1, 2021
EISAI TO LAUNCH PARKINSON’S DISEASE TREATMENT EQUFINA® IN SOUTH KOREA
-
January 29, 2021
-
January 25, 2021
-
January 12, 2021
EISAI TO PRESENT ABSTRACTS ON LENVATINIB AT 2021 GASTROINTESTINAL CANCERS SYMPOSIUM